A BTB extension and ion-binding domain contribute to the pentameric structure and TFAP2A binding of KCTD1.
Journal article
Pinkas DM. et al, (2024), Structure (London, England : 1993)
Discovery of Two Highly Selective Structurally Orthogonal Chemical Probes for Activin Receptor-like Kinases 1 and 2.
Journal article
Němec V. et al, (2024), Journal of medicinal chemistry
Discovery of Conformationally Constrained ALK2 Inhibitors.
Journal article
González-Álvarez H. et al, (2024), Journal of medicinal chemistry
Still in Search for an EAAT Activator: GT949 Does Not Activate EAAT2, nor EAAT3 in Impedance and Radioligand Uptake Assays.
Journal article
van Veggel L. et al, (2024), ACS chemical neuroscience
Discovery and Characterization of a Chemical Probe for Cyclin-Dependent Kinase-Like 2
Journal article
Bashore FM. et al, (2024), ACS Medicinal Chemistry Letters
Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology.
Journal article
Castano A. et al, (2023), eLife, 12
Structural and biochemical characterization establishes a detailed understanding of KEAP1-CUL3 complex assembly
Journal article
Adamson RJ. et al, (2023), Free Radical Biology and Medicine
Discovery of a Potent and Selective CDKL5/GSK3 Chemical Probe That Is Neuroprotective.
Journal article
Ong HW. et al, (2023), ACS Chem Neurosci
Target 2035 – an update on private sector contributions
Journal article
Ackloo S. et al, (2023), RSC Medicinal Chemistry, 14, 1002 - 1011
Disease-associated KBTBD4 mutations in medulloblastoma elicit neomorphic ubiquitylation activity to promote CoREST degradation
Journal article
Chen Z. et al, (2022), Cell Death & Differentiation, 29, 1955 - 1969
Protocol paper: a multi-center, double-blinded, randomized, 6-month, placebo-controlled study followed by 12-month open label extension to evaluate the safety and efficacy of Saracatinib in Fibrodysplasia Ossificans Progressiva (STOPFOP).
Journal article
Smilde BJ. et al, (2022), BMC musculoskeletal disorders, 23
Sequence and structural variations determining the recruitment of WNK kinases to the KLHL3 E3 ligase.
Journal article
Chen Z. et al, (2022), The Biochemical journal
Ubiquitin ligases: guardians of mammalian development
Journal article
Cruz Walma DA. et al, (2022), Nature Reviews Molecular Cell Biology
Target 2035-update on the quest for a probe for every protein
Journal article
Mueller S. et al, (2021), RSC MEDICINAL CHEMISTRY
Development of a Selective Dual Discoidin Domain Receptor (DDR)/p38 Kinase Chemical Probe.
Journal article
Röhm S. et al, (2021), Journal of medicinal chemistry, 64, 13451 - 13474
Challenges and Opportunities for Drug Repositioning in Fibrodysplasia Ossificans Progressiva
Journal article
Ventura F. et al, (2021), Biomedicines, 9, 213 - 213
ALK2 Receptor Kinase Association with FKBP12.6 Is Structurally Conserved with the ALK2-FKBP12 Complex
Journal article
Williams E. et al, (2021), Biomedicines, 9, 129 - 129
DFG-1 Residue Controls Inhibitor Binding Mode and Affinity, Providing a Basis for Rational Design of Kinase Inhibitor Selectivity
Journal article
Schröder M. et al, (2020), Journal of Medicinal Chemistry, 63, 10224 - 10234
Leveraging an Open Science Drug Discovery Model to Develop CNS Penetrant ALK2 Inhibitors for the Treatment of Diffuse Intrinsic Pontine Glioma
Journal article
Smil D. et al, (2020), Journal of Medicinal Chemistry
Sequence and structural variations determining the recruitment of WNK kinases to the KLHL3 E3 ligase
Journal article
Chen Z. et al, (2020)